© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
October 16, 2020
Patients diagnosed with neurologic disorders post-admission were less likely to be discharged home than those with events prior to, or at the time of admission.
October 09, 2020
ELP Pharma readying plans to continue to study the drug in a phase 3 trial.
October 05, 2020
Pupillary light reflex metrics could provide an objective biomarker to determine whether an adolescent athlete has suffered a concussion.
October 03, 2020
History of syncope was present in 17% of the Parkinson group who had an altered blood pressure regulation upon standing and in 10% of those without.
September 25, 2020
The treatment could also be used for Alzheimer disease and mid-stage Huntington disease for patients who suffer from greater cognitive deficits.
September 22, 2020
Those who slept more than 10 hours or less than 4 hours per night declined faster than those who slept about 7 hours per night.
September 19, 2020
Sumifilam could be the first Alzheimer treatment to improve several biomarkers.
September 16, 2020
Favorable neurologic function was slightly higher in a tranexamic acid group than patients taking a placebo.
August 27, 2020
Youth with repeat concussion have worse outcomes and more delays returning to normal life.
August 25, 2020
Approximately 50% of patients with a mTBI who experience fatigue or sleep-wake disturbances 2 weeks following the injury continue to have problems at the 3 month mark.